12:00 AM
 | 
Feb 14, 2011
 |  BC Week In Review  |  Company News  |  Deals

Evotec, Kinaxo deal

Evotec will acquire drug discovery company Kinaxo in a cash and stock deal valued at about €11.7 million ($15.9 million) based on Evotec's close...

Read the full 96 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >